DMM’s Holding Company PT Medela Potentia Tbk Secures Strategic IFC, Strengthens Corporate Fundamentals

Holding company of PT Deca Metric Medica, PT Medela Potentia Tbk (MDLA) has secured a strategic equity investment of IDR 197 billion from the International Finance Corporation (IFC), marking a significant milestone as part of its Initial Public Offering (IPO) on the Indonesia Stock Exchange (IDX) on Tuesday, April 15, 2025.

The investment from IFC—part of the World Bank Group—will support Medela Potentia’s long-term growth strategy, including expanding its domestic distribution network, increasing local production capacity for medical devices, and modernizing its logistics infrastructure with advanced technologies.

This initiative aligns with the Indonesian government’s healthcare transformation agenda, which focuses on strengthening national health resilience and reducing reliance on imported medical devices and pharmaceutical products.

“We are honored by IFC’s support. This is more than just a financial commitment—it’s a strong signal of confidence in our vision and dedication to expanding access to high-quality healthcare solutions. We will continue to invest in innovation, technology, and capacity building to contribute to the sustainable growth of Indonesia’s healthcare sector,” said Krestijanto Pandji, President Director of PT Medela Potentia Tbk.

IFC’s participation underscores the Company’s strong business fundamentals, commitment to good governance, and its strategic role in broadening healthcare access across Indonesia and the region. Medela Potentia stands as one of Indonesia’s trusted healthcare players, contributing to the development of a more self-reliant, innovative, and sustainable health ecosystem.

IFC Country Manager for Indonesia and Timor-Leste Euan Marshall,  emphasized the importance of private sector involvement in strengthening national health systems.

“Our investment in Medela Potentia’s IPO reflects IFC’s commitment to supporting healthcare system development in Indonesia. We are pleased to partner with companies that are leading innovation and delivering long-term impact in vital sectors like healthcare,” he said.

Through this strategic partnership, Medela Potentia continues to strengthen its position as a global healthcare company rooted in Indonesia, serving not only domestic needs but also supporting regional sector growth.

With a solid foundation and strong institutional support, Medela Potentia is confident in delivering lasting value for all stakeholders and playing a meaningful role in advancing national health development in the years to come.